Co-shareholders sell stake in healthcare platform KELIX Bio

Co-shareholders sell stake in healthcare platform KELIX Bio

The platform, created in 2020, has grown rapidly and is about to be acquired by the Abu Dhabi investment giant Mubadala Investment Company. 

Someone shares this article with you
            ▪ Co-shareholders sell stake in healthcare platform KELIX Bio

▪ The platform, created in 2020, has grown rapidly and is about to be acquired by the Abu Dhabi investment giant Mubadala Investment Company. 

https://www.africabusinessplus.com/en/818774/co-shareholders-sell-stake-in-healthcare-platform-kelix-bio/

This article is for subscribers only. To read more, subscribe with a special offer.

You are connected to your Jeune Afrique account but your Africa Business+ subscription does not allow you to consult the English version. To update your subscription, contact us by clicking here.

Recommended articles

New technologies

25/03/2024 at 14h56, by Africa Business+, updated 26/03/2024

Yassine Haddaoui and CDG Invest score double coup in Morocco

CDG Invest SA, a subsidiary of Caisse de dépôt et de gestion marocaine (CDG), is stepping up its role. 

New technologies

29/09/2023 at 17h11, by Aurelie Benoit

DPI backs fintech Ukheshe EFT Corporation takeover

Five years after its creation, the South African start-up is absorbing its counterpart – in business...

Law firm

28/11/2023 at 15h39, by Africa Business+, updated 29/11/2023

Agri-food industry

26/09/2022 at 16h40, by Africa Business+, updated 27/09/2022

Sale of Solevo by Helios : FMO in the running alongside DPI

The acquisition of the pan-African group is of interest to international donors, who are keen to secure...

Any questions ? contact us

Please get in touch with the Africa Business+ team if you require any further information.

Email us : customer.care@africabusinessplus.com

Add AB+ to your home screen

1. Click on + at the bottom of your screen.

2. Click on + to add AB+ on the home screen.

3. Enter the name of the shortcut and confirm.